Strategic partnerships Rose Research Center has a proven track record in clinical trials related to tobacco addiction and cessation, with two North Carolina facilities and a proprietary recruitment network. This presents an opportunity to expand collaborations with public health agencies or pharmaceutical companies focusing on smoking cessation, nicotine alternatives, or addiction medicine.

Government & grants Past work includes a USDA engagement and consumer/trade investigations, indicating experience with government-funded research and regulatory-grade studies. This could translate into opportunities for federally funded clinical trials or contract research for agricultural or health policy-related projects.

Recruitment capacity With a 10,000-subject proprietary database and multi-channel recruitment expertise (TV, print, social, and recruitment websites), the firm can offer fast enrollment for smoking cessation trials or multi-site studies, appealing to sponsors seeking efficient timelines and diverse participant demographics.

Specialized facilities Two full-service, clinically equipped sites in Raleigh and Charlotte with dedicated clinical staff and safety infrastructure (negative pressure rooms, advanced monitoring, storage, and equipment) position RRC as a capable partner for early-phase to late-stage smoking cessation and pharmacological trials.

Technology & analytics Utilization of Marketing and CRM tools (for recruitment) alongside a tech stack including Salesforce and WordPress suggests scalable workflow and data management capabilities. This can be leveraged to offer sponsors robust data capture, participant tracking, and site performance analytics for trial optimization.